Jans Velzing

697 total citations
11 papers, 385 citations indexed

About

Jans Velzing is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jans Velzing has authored 11 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Epidemiology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jans Velzing's work include Cytomegalovirus and herpesvirus research (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Viral Infections and Vectors (3 papers). Jans Velzing is often cited by papers focused on Cytomegalovirus and herpesvirus research (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Viral Infections and Vectors (3 papers). Jans Velzing collaborates with scholars based in Netherlands, Slovakia and Puerto Rico. Jans Velzing's co-authors include Jan Groen, Penelopie Koraka, Albert D. M. E. Osterhaus, Richard Molenkamp, Corine H. GeurtsvanKessel, P H Rothbarth, Kimberley Benschop, Janko van Beek, Marion Koopmans and Zsὁfia Iglὁi and has published in prestigious journals such as PLoS ONE, BMJ and Emerging infectious diseases.

In The Last Decade

Jans Velzing

11 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jans Velzing Netherlands 9 291 177 87 83 46 11 385
Chia Yin Lee Singapore 7 165 0.6× 170 1.0× 12 0.1× 35 0.4× 28 0.6× 8 243
Béatrice M. F. Winkel Netherlands 10 143 0.5× 74 0.4× 75 0.9× 18 0.2× 46 1.0× 13 272
Manu Mabila United States 4 157 0.5× 89 0.5× 10 0.1× 71 0.9× 70 1.5× 5 254
Kaustuv Nayak India 12 205 0.7× 141 0.8× 9 0.1× 112 1.3× 51 1.1× 22 362
Kelly Aparecida Kanunfre Brazil 10 78 0.3× 86 0.5× 17 0.2× 124 1.5× 36 0.8× 21 240
Dane Granger United States 10 319 1.1× 92 0.5× 45 0.5× 72 0.9× 25 0.5× 20 361
David Padley United Kingdom 7 79 0.3× 210 1.2× 13 0.1× 65 0.8× 37 0.8× 9 326
Sergio Gómez‐Medina Germany 11 236 0.8× 129 0.7× 8 0.1× 116 1.4× 42 0.9× 12 350
Nadine Lübke Germany 12 305 1.0× 17 0.1× 47 0.5× 113 1.4× 66 1.4× 46 432
Leonard O. Rollins United States 9 200 0.7× 84 0.5× 7 0.1× 238 2.9× 24 0.5× 10 421

Countries citing papers authored by Jans Velzing

Since Specialization
Citations

This map shows the geographic impact of Jans Velzing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jans Velzing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jans Velzing more than expected).

Fields of papers citing papers by Jans Velzing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jans Velzing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jans Velzing. The network helps show where Jans Velzing may publish in the future.

Co-authorship network of co-authors of Jans Velzing

This figure shows the co-authorship network connecting the top 25 collaborators of Jans Velzing. A scholar is included among the top collaborators of Jans Velzing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jans Velzing. Jans Velzing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Schuit, Ewoud, Irene Veldhuijzen, Roderick P Venekamp, et al.. (2021). Diagnostic accuracy of rapid antigen tests in asymptomatic and presymptomatic close contacts of individuals with confirmed SARS-CoV-2 infection: cross sectional study. BMJ. 374. n1676–n1676. 55 indexed citations
2.
Iglὁi, Zsὁfia, Jans Velzing, R. C. Huisman, et al.. (2021). Clinical evaluation of the SD Biosensor SARS-CoV-2 saliva antigen rapid test with symptomatic and asymptomatic, non-hospitalized patients. PLoS ONE. 16(12). e0260894–e0260894. 15 indexed citations
3.
Iglὁi, Zsὁfia, Jans Velzing, Janko van Beek, et al.. (2021). Clinical Evaluation of Roche SD Biosensor Rapid Antigen Test for SARS-CoV-2 in Municipal Health Service Testing Site, the Netherlands. Emerging infectious diseases. 27(5). 1323–1329. 63 indexed citations
4.
Groen, Jan, et al.. (2000). Evaluation of Six Immunoassays for Detection of Dengue Virus-Specific Immunoglobulin M and G Antibodies. Clinical and Diagnostic Laboratory Immunology. 7(6). 867–871. 114 indexed citations
5.
Groen, Jan, et al.. (1999). Diagnostic value of dengue virus-specific IgA and IgM serum antibody detection. Microbes and Infection. 1(13). 1085–1090. 26 indexed citations
7.
Velzing, Jans, P H Rothbarth, Aloys C.M. Kroes, & Wim Quint. (1994). Detection of cytomegalovirus mRNA and DNA encoding the immediate early gene in peripheral blood leukocytes from immunocompromised patients. Journal of Medical Virology. 42(2). 164–169. 19 indexed citations
8.
Jiwa, Natasha, et al.. (1989). An improved immunocytochemical method for the detection of human cytomegalovirus antigens in peripheral blood leucocytes. Histochemistry and Cell Biology. 91(4). 345–349. 23 indexed citations
9.
Metselaar, Herold J., et al.. (1989). Prophylactic use of anti-CMV immunoglobulins in heart transplant recipients: a study on its safety.. PubMed. 21(1 Pt 3). 2504–5. 2 indexed citations
10.
Metselaar, Herold J., et al.. (1987). A pharmacokinetic study of anti-cytomegalovirus hyperimmunoglobulins in cytomegalovirus seronegative cardiac transplant recipients.. PubMed. 19(5). 4063–5. 8 indexed citations
11.
Rothbarth, P H, et al.. (1987). Rapid demonstration of cytomegalovirus in clinical specimens. Infection. 15(4). 228–231. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026